FDA Device Intelligence
Home › HARDY DIAGNOSTICS › N/A

N/A

HARDY DIAGNOSTICS · Model W95 · UDI-DI 00816576027965

JSJ
10
510(k) clearances
538
Adverse events
6
Recalls
24
Facilities

Description

Liver Infusion Agar Selective, 15x100mm plate, order by the package of 10 (Liver Infusion Selective Agar with Polymyxin B, Nalidixic acid and Vancomycin) For the selective isolation of fungi.

Recalls

DateFirmReason
2026-02-05Remel, IncCustomer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.
2018-08-02Acumedia Manufacturers, Inc.The product is labeled with an incorrect expiration date.
2016-03-21Hardy DiagnosticsPerformance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to produc
2013-06-06Becton Dickinson & Co.Microbiological identification media may exhibit reduced levels of Vancomycin.
2013-06-06Becton Dickinson & Co.Microbiological identification media may exhibit reduced levels of Vancomycin.
2013-06-06Becton Dickinson & Co.Microbiological identification media may exhibit reduced levels of Vancomycin.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.